InMed Conferences and Events
Upcoming Events
Date: May 23-26, 2022
Presentation: The webcast recording will available on this page. Please check back for the link to access the webcast.
Management will be available for virtual one-on-one meetings with institutional and corporate clients of the firm. To request 1-on-1 meetings with the Company, please contact your H.C. Wainwright institutional representative.
More information about the H.C. Wainwright Global Investment Conference can be found here.
Past Events
Date: May 11, 2022
Presentation: The webcast recording will be posted on this page. Check back for the link.
Management will be available for virtual one-on-one meetings with institutional and corporate clients of the firm. To request 1-on-1 meetings with the Company, please contact your Canaccord institutional representative. More information on the Canaccord Cannabis Conference can be found here.
Date: April 20-21, 2022
Management will be available for virtual one-on-one meetings with institutions and industry representatives. To request 1-on-1 meetings with the Company please contact investor relations at [email protected]
Date: March 13-15, 2022
InMed Pharmaceuticals will be presenting at the upcoming 34th Annual Roth Conference in Orange Country, CA March 13-15, 2022.
Watch the fireside chat with InMed CEO, Eric A. Adams and Roth Analyst Scott Henry:
https://wsw.com/webcast/roth43/inm2/1748056
InMed Presentation webcast link: https://wsw.com/webcast/roth43/inm/1677456
Date: Tuesday, February 15, 2022
Time: 11:00am PT / 2:00pm ET
Conference Call & Webcast*:
Tuesday, February 15, 2022, at 11:00 AM Pacific Time, 02:00 PM Eastern Time
US/CANADA Participant Toll-Free Dial-In Number: +1 (855) 605-1745
US/CANADA Participant International Dial-In Number: +1 (914) 987-7959
Conference ID: 8645175
Webcast: https://edge.media-server.com/mmc/p/sa6ykfmv
(*Webcast replay available for 90 days)
The Company’s full financial statements and related MD&A for the second quarter of fiscal year 2022, ended December 31, 2021 will be available at www.inmedpharma.com, www.sedar.com and at www.sec.gov on February 15, 2022.
Date: Thursday, January 20, 2022
Time: 1:30pm ET
InMed presenting at the KCSA Cannabis Virtual Investor Conference this Thursday at 1:30pm ET. President and CEO, Eric A. Adams to present.
Register free to participate. https://www.virtualinvestorconferences.com/events/event-details/kcsa-cannabis-virtual-investor-conference-0?utm_source=Virtual+Investor+Conference
Date: January 6, 2022
Time: 8:00am PT/ 11:00am ET
We are excited to be hosting Tribe Public’s Next Webinar Presentation and Q&A Event which will be held Thursday, January 6, 2022 (8 am PT/ 11 am ET). Our events are approximately 30 minutes in duration.
Eric A. Adams, CEO & President of InMed Pharmaceuticals, SVP, General Manager of BayMedica Shane Johnson, & VP, Commercial Operations Chris Meiering, PhD will co-host a presentation and Q&A event titled “Addressing The Increasing Demand For Rare Cannabinoids”. There will be a 5-10 minute Q&A session at the end of the presentation, so please send your questions for management to Tribe’s email: [email protected]
Date: November 29th – December 1st, 2021
Time: 8:00 am
InMed Pharmaceuticals will be attending Cowen’s 4th Annual Cannabis Conference. The company will be conducting virtual one-on-one meetings.
This three-day conference will comprise topical panel discussions with C-Suite presenters hosted by Cowen Research and Washington Research Group analysts & along with virtual one-on-one meetings.
*Cowen conferences and events are intended for institutional clients and corporate clients of the firm. They are not open to media or retail investors.
For more information on the conference, visit Cowen’s webpage at https://www.cowen.com/conferences-and-events/4th-annual-cannabis-conference/
Date: September 29th, 2021
Time: 11:55am ET
InMed Pharmaceuticals’ Eric Hsu, Senior Vice President of Preclinical Research and Development, will join the panel discussion “Pharmaceutical Cannabinoids and their Impact on Treatments for Complex Diseases”
To learn more about the Benzinga Healthcare Conference and tune into the panel discussion, join here: https://www.benzinga.com/events/small-cap/healthcare/
Date: Friday, September 24, 2021
Time: 8:00 AM Pacific Time, 11:00 AM Eastern Time
InMed Pharmaceuticals will report financial results for the fiscal year ended June 30, 2021, on Friday, September 24, 2021.
US/CANADA Participant Toll-Free Dial-In Number: +1 (855) 605-1745
US/CANADA Participant International Dial-In Number: +1 (914) 987-7959
Conference ID: 9373618
Webcast: https://edge.media-server.com/mmc/p/ny89uo2r
(*Webcast replay available for 90 days)
The Company’s full financial statements and related MD&A for the fiscal year ended June 30, 2021 will be available at www.inmedpharma.com, www.sedar.com and at www.sec.gov on September 24, 2021.
Date: September 16, 2021
Time: 11:00am ET
As announced on September 13, InMed has signed a definitive agreement to acquire BayMedica, a leading commercial manufacturer of rare cannabinoids.
InMed and BayMedica invite you to join a webinar to learn more about this transaction and to hear about InMed’s future developments.
Join InMed’s CEO, Eric A. Adams, and BayMedica’s co-founder, Shane Johnson, for the webinar, hosted by Edison Research, on Thursday September 16, 2021 at 11:00 am ET.
Watch a replay of the webinar here.
